IL123595A - Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them - Google Patents

Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them

Info

Publication number
IL123595A
IL123595A IL12359596A IL12359596A IL123595A IL 123595 A IL123595 A IL 123595A IL 12359596 A IL12359596 A IL 12359596A IL 12359596 A IL12359596 A IL 12359596A IL 123595 A IL123595 A IL 123595A
Authority
IL
Israel
Prior art keywords
taxane
hydrolysis
promoting
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL12359596A
Other languages
English (en)
Other versions
IL123595A0 (en
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of IL123595A0 publication Critical patent/IL123595A0/xx
Publication of IL123595A publication Critical patent/IL123595A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
IL12359596A 1995-09-12 1996-09-12 Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them IL123595A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US357595P 1995-09-12 1995-09-12
PCT/US1996/014631 WO1997010234A1 (en) 1995-09-12 1996-09-12 Hydrolysis-promoting taxane hydrophobic derivatives

Publications (2)

Publication Number Publication Date
IL123595A0 IL123595A0 (en) 1998-10-30
IL123595A true IL123595A (en) 2000-10-31

Family

ID=21706522

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12359596A IL123595A (en) 1995-09-12 1996-09-12 Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US5703117A (xx)
EP (1) EP0902783B1 (xx)
JP (1) JP4192208B2 (xx)
KR (1) KR100401220B1 (xx)
CN (1) CN1100770C (xx)
AT (2) ATE216377T1 (xx)
CA (1) CA2231750C (xx)
CZ (1) CZ288562B6 (xx)
DE (2) DE69620802T2 (xx)
DK (2) DK0902783T3 (xx)
ES (2) ES2179208T3 (xx)
HK (1) HK1016169A1 (xx)
HU (1) HU226325B1 (xx)
IL (1) IL123595A (xx)
MX (1) MX9801871A (xx)
NO (1) NO319521B1 (xx)
NZ (1) NZ318300A (xx)
PL (1) PL187738B1 (xx)
PT (1) PT902783E (xx)
SK (1) SK283199B6 (xx)
TR (1) TR199800443T1 (xx)
WO (1) WO1997010234A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) * 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1964557B1 (en) 1997-11-10 2013-01-02 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations
BR9911031A (pt) * 1998-05-20 2002-01-29 Liposome Co Inc Novas formulações em partìculas
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
DE60004630T2 (de) * 1999-01-12 2004-06-17 Quanam Medical Corp., Santa Clara Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
EP1301500B1 (en) 2000-06-22 2007-11-21 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) * 2000-08-29 2003-08-19 Micron Technology, Inc. Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (en) * 2001-10-22 2008-12-31 Viroblock SA New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
CA2466851C (en) * 2001-11-26 2012-09-11 Supergen, Inc. Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
EP1553924B1 (en) * 2002-06-26 2010-12-08 MediGene AG Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
BRPI0407096A (pt) 2003-02-03 2006-01-24 Neopharm Inc Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
WO2006089207A2 (en) * 2005-02-18 2006-08-24 Abraxis Bioscience, Inc. Drugs with improved hydrophobicity for incorporation in medical devices
US8173167B2 (en) 2005-04-12 2012-05-08 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
MX2010011165A (es) * 2008-04-10 2011-02-22 Abraxis Bioscience Llc Composiciones de derivados de taxano hidrofobos y sus usos.
KR20150136137A (ko) * 2008-04-10 2015-12-04 아브락시스 바이오사이언스, 엘엘씨 소수성 탁산 유도체의 조성물 및 그의 용도
WO2011038278A2 (en) 2009-09-25 2011-03-31 Wisconsin Alumni Research Foundation Micelle encapsulation of therapeutic agents
CN105503844A (zh) * 2015-12-11 2016-04-20 上海大学 C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
DK1251127T3 (da) * 1992-12-23 2006-03-06 Bristol Myers Squibb Co Nye sidekædede-bærende taxaner og mellemprodukter deraf
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives

Also Published As

Publication number Publication date
PT902783E (pt) 2002-09-30
NO319521B1 (no) 2005-08-22
CA2231750A1 (en) 1997-03-20
IL123595A0 (en) 1998-10-30
ES2179208T3 (es) 2003-01-16
DE69635428T2 (de) 2006-06-14
HUP9901433A3 (en) 2001-05-28
DE69635428D1 (de) 2005-12-15
CN1100770C (zh) 2003-02-05
EP0902783B1 (en) 2002-04-17
NO981071D0 (no) 1998-03-11
DE69620802D1 (de) 2002-05-23
CA2231750C (en) 2006-07-11
WO1997010234A1 (en) 1997-03-20
ATE309235T1 (de) 2005-11-15
PL325477A1 (en) 1998-07-20
JP4192208B2 (ja) 2008-12-10
CZ288562B6 (cs) 2001-07-11
KR100401220B1 (ko) 2004-03-20
TR199800443T1 (xx) 1998-06-22
ES2252347T3 (es) 2006-05-16
ATE216377T1 (de) 2002-05-15
AU706290B2 (en) 1999-06-10
EP0902783A1 (en) 1999-03-24
JP2001519755A (ja) 2001-10-23
NZ318300A (en) 1999-08-30
EP0902783A4 (xx) 1999-03-24
KR19990044409A (ko) 1999-06-25
PL187738B1 (pl) 2004-09-30
AU6975696A (en) 1997-04-01
NO981071L (no) 1998-05-12
DK1229030T3 (da) 2006-02-13
CN1202166A (zh) 1998-12-16
DK0902783T3 (da) 2002-07-22
SK33498A3 (en) 1998-08-05
HK1016169A1 (en) 1999-10-29
CZ71198A3 (cs) 1998-07-15
SK283199B6 (sk) 2003-03-04
US5703117A (en) 1997-12-30
HUP9901433A2 (hu) 2001-04-28
DE69620802T2 (de) 2002-10-10
MX9801871A (es) 1998-05-31
HU226325B1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
IL123595A (en) Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them
IL133585A0 (en) Soluble prodrugs of paclitaxel
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
EP1033981A4 (en) FORMULATIONS AND METHODS FOR REDUCING THE TOXICITY OF ANTINEOPLASTIC AGENTS
MX9710228A (es) Nuevos analogos de camptotecina, procedimientos de preparacion, su aplicacion como medicinas y las composiciones farmaceuticas que los comprenden.
SE9301951D0 (sv) Methods for administration of taxol
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
AU1406895A (en) Inhalable contrast agent
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
DK0975595T3 (da) Kokainanaloger
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
FR2616330B1 (fr) Agent actif et medicament en contenant destines a prevenir ou a combattre le rejet de greffe d'organe chez l'homme
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
EP1229030A3 (en) Hydrolysis-promoting taxane hydrophobic derivates
JPS6485930A (en) Anticancer composition and therapy using monoclonal antibody and il-2 against gd3 ganglioside
IL112668A (en) 4-Amino 6-substituted mycophenolic acid and derivatives thereof their preparation and pharmaceutical compositions containing them
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
IL117564A (en) Pharmaceutical and diagnostic compositions containing lysine derivatives
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs
FI862561A (fi) Foerfarande foer framstaellning av ergolinderivat.
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.
NZ335189A (en) Use of taxane hydrophobic derivatives for the treatment of cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees